Literature DB >> 19707759

Atypical rapid progression of osteoarticular amyloidosis involving the hip in a patient on hemodialysis using polyacrylonitrile membranes.

Kenneth S Lee1, Marnix T van Holsbeeck, Alexander Abbud.   

Abstract

Amyloidosis related to dialysis is a well-known complication affecting many organ systems, in particular the musculoskeletal system. In 1985 Shirahama et al. (Biochem Biophys Res Commun 53:705-709, 1985) identified beta-2 microglobulin (MG) as the offending constituent by using protein purification techniques. Amyloidosis has been increasing in prevalence because of longer life spans and increased chronic medical conditions such as end-stage renal disease. When dialysis-related amyloidosis involves the musculoskeletal system, it affects the shoulder girdle, the so called shoulder pad sign, the wrist, hip, knee, and spine (Resnick, Diagnosis of bone and joint disorders, 4th edn., pp. 2054-2058 and 2176-2183, 2002). Other osteoarticular manifestations of amyloidosis include osteoporosis, lytic lesions, and pathologic fractures. It has been well documented that the prevalence of amyloid is dependent on duration of dialysis-over 90% in patients on dialysis for over 7 years (Jadoul, Nephrol Dial Transplant 13:61-64, 1998). However, a recent changeover to high-flux membranes used in hemofiltration has been reported to delay its onset (Campistol et al., Contrib Nephrol 125:76-85, 1999). We report on the radiographic, nuclear medicine, and computed tomography (CT) findings of osteoarticular amyloidosis involving the hip, and sequence its atypical rapid onset. The imaging, histopathological findings, and differential diagnosis are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19707759     DOI: 10.1007/s00256-009-0779-6

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  24 in total

1.  Dialysis amyloid: the bottom line.

Authors:  Mark A Little; Michelle Cafferky; Shyamsundar Menon; Ken Farrington
Journal:  Nephrol Dial Transplant       Date:  2005-02       Impact factor: 5.992

2.  Therapeutic plasma exchange performed in tandem with hemodialysis for patients with M-protein disorders.

Authors:  Aftab Mahmood; Donata Sodano; Anthony Dash; Robert Weinstein
Journal:  J Clin Apher       Date:  2006-07       Impact factor: 2.821

3.  Early destructive spondyloarthropathy from combined beta2-microglobulin and transthyretin Met30 amyloidosis in a dialysed patient.

Authors:  I Beirão; L Lobato; S M Guimarães; P Cardoso; P M Costa; T Coelho; G Rocha; S Guimarães
Journal:  Nephrol Dial Transplant       Date:  1998-12       Impact factor: 5.992

Review 4.  Beta-2-microglobulin removal by hemodialysis with polymethylmethacrylate membranes.

Authors:  J M Campistol; J V Torregrosa; E Ponz; B Fenollosa
Journal:  Contrib Nephrol       Date:  1999       Impact factor: 1.580

5.  Growing bone cysts in long-term hemodialysis.

Authors:  J L Gielen; M T van Holsbeeck; D Hauglustaine; L Verresen; E Verbeken; A L Baert; L Meeus; P Vandevoorde; P Michielsen; A Coral
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

Review 6.  Pathogenesis and management of dialysis-related amyloid bone disease.

Authors:  M Nangaku; T Miyata; K Kurokawa
Journal:  Am J Med Sci       Date:  1999-06       Impact factor: 2.378

7.  Electron microscopic characteristics of beta2-microglobulin amyloid deposits in long-term haemodialysis.

Authors:  Miklós Bély; Pál Kapp; Tamás Szentjóbi Szabó; Tamás Lakatos; Agnes Apáthy
Journal:  Ultrastruct Pathol       Date:  2005 Nov-Dec       Impact factor: 1.094

8.  Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as beta 2-microglobulin.

Authors:  T Shirahama; M Skinner; A S Cohen; F Gejyo; M Arakawa; M Suzuki; Y Hirasawa
Journal:  Lab Invest       Date:  1985-12       Impact factor: 5.662

Review 9.  Dialysis-related amyloidosis: importance of biocompatibility and age.

Authors:  M Jadoul
Journal:  Nephrol Dial Transplant       Date:  1998       Impact factor: 5.992

10.  Long-term multicentre study on beta 2-microglobulin removal by PMMA BK membrane.

Authors:  M Arakawa
Journal:  Nephrol Dial Transplant       Date:  1991       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.